Here's how PMC.NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

PMC . NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Pmc.ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Social Networks
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We are analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC4167493/.

Title:
AXL mediates resistance to cetuximab therapy - PMC
Description:
The EGFR antibody cetuximab is used to treat numerous cancers, but intrinsic and acquired resistance to this agent is a common clinical problem. In this study we show that overexpression of the oncogenic receptor kinase AXL is sufficient to mediate ...
Website Age:
27 years and 9 months (reg. 1997-10-02).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is pmc.ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Pmc.ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of pmc.ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,004,336 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Pmc.ncbi.nlm.nih.gov Make Money? {💸}

We don’t know how the website earns money.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Pmc.ncbi.nlm.nih.gov might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

axl, cetuximab, doi, egfr, cells, ctxr, resistance, cell, cancer, clones, figure, pubmed, google, scholar, expression, growth, activation, proliferation, signaling, pmc, tumors, acquired, resistant, mapk, article, data, treated, analysis, free, receptor, hnscc, tyrosine, sirna, increased, tumor, control, igg, antibody, role, treatment, pdxs, usa, mab, mrna, antiaxl, prior, kinase, overexpressed, factor, line,

Topics {✒️}

hrp-conjugated goat-anti-rabbit igg robust anti-proliferative responses robust anti-proliferative effects elicited anti-proliferative responses patient-derived tumor xenografts donkey-anti-goat igg bamh1/ecor1 restriction sites triple-negative breast cancers patient-derived xenografts established anti-axl monoclonal antibody pmc beta search ras/raf/mek/erk mapk/c-jun signaling pathway goat-anti-mouse igg small-cell lung cancer line taxane/carboplatin chemotherapy transcription factor c-jun early-stage colon cancer shown anti-tumorigenic effects hyperactivated mapk/c-jun signaling phospho axl-y779 antibody ctxr clones post-treatment ctxs cell line de novo models treat cetuximab-resistant cancers tumor xenograft assays squamous-cell carcinoma hp-axl stable cells united states government paxl-y779 expression levels gene expression profile anti-axl tki r428 small interfering rna receptor tyrosine kinases license information pmcid monoclonal antibody mab173 supplementary materials included single cell clones cetuximab-sensitive parental cells nih national center egfr-dependent ctxr cells researchers demonstrated axl ctxs parental cells growth inhibitory effects igg grew rapidly anti-axl antibody early passaged pdxs axl receptor played egfr kinase inhibitors positive feedback loop

Social Networks {👍}(6)

External Links {🔗}(185)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

Name Servers:

  • ns-cloud-e1.googledomains.com
  • ns-cloud-e2.googledomains.com
  • ns-cloud-e3.googledomains.com
  • ns-cloud-e4.googledomains.com

CDN Services {📦}

  • Ncbi

4.52s.